Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2023-09-20 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and changes in capital, not a full financial report or earnings release. It is not an announcement of a report publication but a detailed disclosure of share transactions by the company. This fits the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-09-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares over various dates, confirming compliance with listing rules and legal requirements. The content focuses on share repurchase transactions and confirmations related to these capital changes. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about share repurchases, fitting the category of a report on transactions in own shares (share buybacks). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2023-09-19 English
Notification Letter and Request Form to Non-registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a notification letter addressed to non-registered shareholders informing them about the publication of the company's Interim Report 2023 on the company's website. It provides instructions on how shareholders can access the report online or request a printed copy. The document does not contain the actual interim report or substantive financial data but serves as a communication about the availability of the report. The document length is 7445 characters, which is relatively short and consistent with a notification rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement of the report's publication, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2023-09-19 English
2023 Interim Report
Interim / Quarterly Report Classification · 100% confidence The document is titled '2023 Interim Report' and contains detailed sections such as Business Review and Outlook, Management Discussion and Analysis, Independent Review Report, and Interim Condensed Consolidated Financial Statements including Profit or Loss, Financial Position, Changes in Equity, Cash Flows, and Notes to Interim Condensed Consolidated Financial Information. The reporting period is explicitly stated as the six months ended June 30, 2023, which aligns with an interim or quarterly report. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-09-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details multiple repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The content is focused on reporting share repurchase transactions and capital changes, not on financial results, management changes, or other report types. This matches the definition of 'Transaction in Own Shares' filings, which report company buybacks or sales of its own shares. The document length is over 14,000 characters and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2023-09-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a full financial report or earnings release. It is a formal regulatory filing required by the Stock Exchange of Hong Kong to disclose share capital changes and buybacks. Therefore, it fits best under the category 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2023-09-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.